genetic linkage analysis
genetic linkage analysis is a genetic therapy with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Studying Genes for Barrett's Esophagus in Brothers and Sisters
Clinical Trials (6)
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
Studying Genes for Barrett's Esophagus in Brothers and Sisters
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
All 6 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 6